Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Taro Pharmaceutical Industries Ltd. (TARO)

100.54   -0.8 (-0.79%) 05-17 16:02
Open: 101.35 Pre. Close: 101.34
High: 102.11 Low: 99.72
Volume: 94,676 Market Cap: 3923M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 102.777 - 103.763 103.763 - 104.359
Low: 97.613 - 98.909 98.909 - 99.693
Close: 99.059 - 101.162 101.162 - 102.433

Technical analysis

as of: 2019-05-17 4:31:55 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 123.47     One year: 127.80
Support: Support1: 99.72    Support2: 82.97
Resistance: Resistance1: 105.71    Resistance2: 109.42
Pivot: 105.26
Moving Average: MA(5): 102.54     MA(20): 105.64
MA(100): 100.86     MA(250): 103.88
MACD: MACD(12,26): -0.99     Signal(9): -0.29
Stochastic oscillator: %K(14,3): 8.60     %D(3): 14.51
RSI: RSI(14): 31.06
52-week: High: 121.23  Low: 76.93  Change(%): -11.0
Average Vol(K): 3-Month: 6757  10-Days: 6167

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TARO has closed below the lower band by 1.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 5.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 09 May 2019 16:59:14 Z
Taro Pharmaceutical (TARO) Earnings Expected to Grow: Should You Buy?

Thu, 21 Mar 2019 14:18:42 Z featured expert Kevin Matras highlights: Unilever, Rent-A-Center, Abercrombie & Fitch, Taro Pharmaceutical and PCTEL

Wed, 20 Mar 2019 16:12:45 Z
Buy These 5 Low-Beta Stocks to Survive the Volatility Scare

Fri, 08 Mar 2019 16:21:34 Z
Moving Average Crossover Alert: Taro Pharmaceutical

Thu, 07 Mar 2019 23:08:47 Z
Notable Two Hundred Day Moving Average Cross - TARO

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 39.02
Shares Float (M) 39.02
% Held by Insiders
% Held by Institutions 14.40
Shares Short (K) 250
Shares Short P. Month (K)

Stock Financials

EPS Est. Current Year 9.490
EPS Est. Next Year 7.990
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 2.250
PEG Ratio -1.03
Profit Margin 45.64
Operating Margin 43.85
Return on Assets (ttm) 14.1
Return on Equity (ttm) 15.7
Qtrly Rev. Growth 13.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 420.30
Operating Cash Flow (M) 363.02
Levered Free Cash Flow (M) 281.44

Stock Valuations

P/E Growth Ratio
P/BV 44.68
P/S 231723024.00
P/CF 10.81

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-12-28
Ex-Dividend Date 2018-12-10
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.